跳至主要内容
临床试验/NCT02788786
NCT02788786已完成2 期

Feasibility and Acceptability of Daily Oral Rinse in Pregnant Women and Impact on Oral Inflammatory Biomarkers in Rural Nepal

Johns Hopkins Bloomberg School of Public Health1 个研究点 分布在 1 个国家目标入组 175 人开始时间: 2016年6月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
175
试验地点
1
主要终点
Acceptability

研究概览

简要总结

In Nepal, investigators are conducting a cohort study to estimate the relationship between signs of periodontal disease in pregnant women and preterm delivery. Within that cohort study, investigators plan to conduct an individually randomized trial of the acceptability and effect chlorhexidine, cetylpyridinium chloride, and salt water oral rinses on gingival crevicular fluid and plaque during pregnancy. Women for this pilot trial will be chosen from a subset of the area currently engaged in the larger cohort study, to simplify logistics. The pilot trial will have four arms (three oral rinse arms, and one control group).

  • Arm 1: Twice daily oral rinse containing chlorhexidine 0.12% w/v (n=25 women with periodontitis
  • Arm 2: Twice daily oral rinse with cetylpyridinium chloride (n=50; 25 women with/without periodontitis)
  • Arm 3: Twice daily oral rinse with salt and water (n=50: 25 women with/without periodontitis)
  • Arm 4: No oral rinse (n=50)

To select and enroll these 175 participants, data collectors will use the information they collected during an oral health clinical examination conducted at the time of enrollment into the broader cohort study; this information will be used to classify women by signs of periodontitis.

Those selected through this above process will be read an additional consent form; those agreeing to participate will be provided with a supply of their assigned rinse (and instructions on its use and handling/storage), or no rinse. Those in the three rinse groups will be asked to use the provided rinse twice per day after brushing and to save the empty bottles for collection by the health care worker. At the end of this first visit, women will additionally provide a venous blood sample to measure systemic inflammation markers and fluoride.

Women receiving the rinse will be visited by study workers periodically to provide more oral rinse and check on their adherence to the rinse. All 175 women will be visited after 12 weeks to undergo a second oral health clinical examination and provide a second set of gingival crevicular fluid and plaque samples, to allow for evaluation of the effect of each of the oral rinses as compared to the normal physiological changes in gingival inflammation and biofilm composition during the course of pregnancy.

At this final visit, the women in the three rinse arms will also answer a short questionnaire to gather feedback on acceptability and adherence to the oral rinse.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • <26 weeks gestation at enrollment
  • Enrolled in the broader cohort study

排除标准

  • Already previously enrolled
  • Not Pregnant

研究组 & 干预措施

chlorhexidine

Experimental

0.12% w/v chlorhexidine oral rinse; 15ml, twice-daily, for 12 weeks

干预措施: Chlorhexidine (Drug)

cetylpyridinium chloride

Experimental

non-alcoholic cetylpyridinium chloride oral rinse; 15ml, twice-daily, for 12 weeks

干预措施: Cetylpyridinium chloride (Drug)

Salt and Water

Active Comparator

Salt and water based oral rinse; 15ml, twice-daily, for 12 weeks

干预措施: Salt and Water (Drug)

结局指标

主要结局

Acceptability

时间窗: 12 weeks

Do women accept the use of their assigned oral rinse?

Inflammatory markers in gingival crevicular fluid (IL-1β, IL-6, IL-10, TNF-α, PGE2, and GM-CSF)

时间窗: 12 weeks

Do the oral rinses (or no rinse) have differing impacts on inflammatory markers in gingival crevicular fluid. Specifically, IL-1β, IL-6, IL-10, TNF-α, PGE2, and GM-CSF will be measured (pg/ml) using validated multiplex immunoassays.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验